Pembrolizumab vs best supportive care for second-line advanced hepatocellular carcinoma: Randomized, phase 3 KEYNOTE-240 study

Richard S. Finn, Stephen L. Chan, Andrew X. Zhu, Jennifer J. Knox, Ann‐Lii Cheng, A.B. Siegel, O. Bautista, P.A. Watson, Masatoshi Kudo

Annals of Oncology · 2016 · 11 citations · 0 references

DOIFull text

Open access

Concepts